The State of China Biotech 2010 - Part II

Technology development and clinical trial activity

310 views

Share:

More...

00:08:03 - Uploaded by Song Essinova, LLC on January 27, 2010

China’s life science industry is moving quickly from services to innovation. In the 2010 ChinaBio Executive Workshop "Leveraging China to Build a Global Biotech", hosted at Morrison & Foerster's San Francisco office during the 28th JP Morgan Healthcare Conference, Greg Scott presents the latest update on China's government programs, novel technology development, investment, M&A and partnering deals, and other data from ChinaBio’s research team.

Watch this video series for not only hot-off-the-press facts and figures, but also stories and anecdotes witnessed or experienced by a pioneering firm, on the frontline of bio-business in the world's fastest growing but complex country.

Tags: China, ChinaBio, Greg Scott, China biotech, patent, clinical trial, preclinical

RELATED

• China - Half Way Up the Value Chain, and Rapidly Growing: A Conversation with Charles Hsu, Bay City Capital
• The State of China Biotech 2010-Part III-VC investments, M&A, IPO and joint venture activities (membership required)
• The State of China Biotech 2010-Part I-Driving factors and government programs